ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04658	Th1 and Th2 cell differentiation	13/129	96/7206	1.20749603372e-08
ko05168	Herpes simplex infection	17/129	182/7206	1.97099716995e-08
ko05162	Measles	14/129	120/7206	2.28955281935e-08
ko05164	Influenza A	16/129	167/7206	3.71723107211e-08
ko04659	Th17 cell differentiation	13/129	106/7206	4.09148941966e-08
ko04621	NOD-like receptor signaling pathway	15/129	157/7206	1.06319028718e-07
ko04060	Cytokine-cytokine receptor interaction	16/129	191/7206	2.44230353807e-07
ko05145	Toxoplasmosis	13/129	126/7206	3.24203953978e-07
ko05340	Primary immunodeficiency	7/129	30/7206	7.23310902274e-07
ko04380	Osteoclast differentiation	12/129	134/7206	4.27907046876e-06
ko04650	Natural killer cell mediated cytotoxicity	10/129	97/7206	8.01263582706e-06
ko04612	Antigen processing and presentation	9/129	77/7206	8.24168567317e-06
ko04620	Toll-like receptor signaling pathway	10/129	100/7206	1.0539331798e-05
ko04660	T cell receptor signaling pathway	11/129	124/7206	1.19975980652e-05
ko04622	RIG-I-like receptor signaling pathway	8/129	62/7206	1.27466308477e-05
ko04630	Jak-STAT signaling pathway	11/129	132/7206	2.17504143455e-05
ko05140	Leishmaniasis	8/129	75/7206	5.23484851854e-05
ko05161	Hepatitis B	12/129	173/7206	5.70790872844e-05
ko05152	Tuberculosis	12/129	187/7206	0.000120985803033
ko05133	Pertussis	8/129	87/7206	0.000151516070464
ko04064	NF-kappa B signaling pathway	8/129	96/7206	0.000300565891677
ko03050	Proteasome	6/129	54/7206	0.000374202471095
ko05160	Hepatitis C	10/129	153/7206	0.000392122042569
ko05150	Staphylococcus aureus infection	5/129	36/7206	0.000410837229576
ko05321	Inflammatory bowel disease (IBD)	6/129	56/7206	0.000456890898054
ko04672	Intestinal immune network for IgA production	5/129	37/7206	0.000468281440125
ko04610	Complement and coagulation cascades	7/129	79/7206	0.000497648941129
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/129	191/7206	0.000592941010994
ko04623	Cytosolic DNA-sensing pathway	5/129	41/7206	0.000760324646084
ko05330	Allograft rejection	4/129	24/7206	0.000788935953619
ko04062	Chemokine signaling pathway	11/129	201/7206	0.000906901194849
ko05320	Autoimmune thyroid disease	4/129	29/7206	0.00164559769927
ko05166	HTLV-I infection	13/129	292/7206	0.00209993243522
ko05416	Viral myocarditis	5/129	55/7206	0.00289112292899
ko05310	Asthma	3/129	17/7206	0.00317196277318
ko05131	Shigellosis	6/129	82/7206	0.00337588898325
ko05332	Graft-versus-host disease	3/129	18/7206	0.00375697400837
ko04666	Fc gamma R-mediated phagocytosis	7/129	122/7206	0.00610559953927
ko05202	Transcriptional misregulation in cancer	9/129	188/7206	0.00642788538438
ko04145	Phagosome	8/129	162/7206	0.0083880401419
ko05142	Chagas disease (American trypanosomiasis)	7/129	130/7206	0.00856444025583
ko05169	Epstein-Barr virus infection	9/129	206/7206	0.0113880300166
ko04217	Necroptosis	8/129	178/7206	0.0142972981508
ko04940	Type I diabetes mellitus	3/129	32/7206	0.0190431270047
ko04668	TNF signaling pathway	6/129	120/7206	0.020365992274
ko04662	B cell receptor signaling pathway	5/129	88/7206	0.0204317993029
ko05323	Rheumatoid arthritis	5/129	89/7206	0.0213466434465
ko00760	Nicotinate and nicotinamide metabolism	3/129	34/7206	0.0223901221367
ko04514	Cell adhesion molecules (CAMs)	6/129	130/7206	0.0288189480638
ko05144	Malaria	3/129	45/7206	0.0461163783382
ko05215	Prostate cancer	5/129	111/7206	0.0485009056598
ko04664	Fc epsilon RI signaling pathway	4/129	77/7206	0.0487589826315
ko00120	Primary bile acid biosynthesis	2/129	20/7206	0.0489684736446